Clinical Trials Directory

Trials / Unknown

UnknownNCT06280430

Vascular Affection in Behcet Disease

Serum Elafin :A Biomarker in Behcet Disease and Its Relation to Vascular Involvement and Disease Activity

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
20 Years – 45 Years
Healthy volunteers

Summary

To measure the level of serum elafin in patients with behcet disease and to assess the correlation between serum elafin and vascular affection and their relation with disease activity

Detailed description

Behcet disease is a chronic multi systemic inflammatory disease characterized by recurrent oral and genital ulcers and multiple systemic affection . Elafin is a serine protease inhibitor produced mainly by epithelial cells . previous studies documented the role of serum elafin in pathogenesis of behcet disease.vascular complications may be one if the earliest manifestation leading to the diagnosis of behcet disease.

Conditions

Timeline

Start date
2024-03-01
Primary completion
2025-03-01
Completion
2025-04-01
First posted
2024-02-28
Last updated
2024-02-28

Source: ClinicalTrials.gov record NCT06280430. Inclusion in this directory is not an endorsement.

Vascular Affection in Behcet Disease (NCT06280430) · Clinical Trials Directory